Metoprolol succinate and Dysgraphia - a phase IV clinical study of FDA data

Summary:

Dysgraphia is reported as a side effect among people who take Metoprolol succinate (metoprolol succinate), especially for people who are female, 40-49 old, also take Aspirin, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Dysgraphia when taking Metoprolol succinate. It is created by eHealthMe based on reports of 64,247 people who have side effects when taking Metoprolol succinate from the FDA, and is updated regularly.

What is Metoprolol succinate?

Metoprolol succinate has active ingredients of metoprolol succinate. It is often used in high blood pressure. eHealthMe is studying from 66,933 Metoprolol succinate users. Check the latest studies of Metoprolol succinate.

What is Dysgraphia?

Dysgraphia (impaired ability to learn to write) is found to be associated with 564 drugs and 648 conditions by eHealthMe. Check the latest studies of Dysgraphia.

On Jul, 05, 2026

64,247 people reported to have side effects when taking Metoprolol succinate.
Among them, 15 people (0.02%) have Dysgraphia.

Could Metoprolol succinate cause Dysgraphia?

Among these 15 people:

What is the gender of people who have Dysgraphia when taking Metoprolol succinate? *

female: 53.33 %
male: 46.67 %

What is the age of people who have Dysgraphia when taking Metoprolol succinate? *

What are other drugs people take besides Metoprolol succinate? *

What are other side effects people have besides Dysgraphia? *

Tremor (trembling or shaking movements in one or more parts of your body): 5 people, 33.33%
Gait Disturbance: 4 people, 26.67%
Fatigue (feeling of tiredness): 3 people, 20.00%
Drug Ineffective: 3 people, 20.00%
Weight Decreased: 3 people, 20.00%
Sleep Disorder: 3 people, 20.00%
Fall: 3 people, 20.00%
Pain: 3 people, 20.00%
Diarrhea: 3 people, 20.00%
Weakness: 3 people, 20.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 20.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 13.33%
Cardiac Disorder: 2 people, 13.33%
High Blood Cholesterol: 2 people, 13.33%
Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 2 people, 13.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 13.33%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 6.67%
Electrolyte Imbalance: 1 person, 6.67%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 6.67%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Metoprolol succinate and have Dysgraphia?

- Check whether Dysgraphia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Metoprolol succinate:

Metoprolol succinate (66,933 reports)

Dysgraphia treatments and more:

Dysgraphia (7,998 reports)

Browse all side effects of Metoprolol succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dysgraphia:

Dysgraphia (564 drugs)

Browse all the conditions that are associated with Dysgraphia:

Dysgraphia (648 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol succinate (the active ingredients of Metoprolol succinate) and Metoprolol succinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.